Evidence map›Paper›PMID 19672294›Full record

ArticlePloS one2009

Vav links the T cell antigen receptor to the actin cytoskeleton and T cell activation independently of intrinsic Guanine nucleotide exchange activity.

Ana V Miletic, Daniel B Graham, Kumiko Sakata-Sogawa, Michio Hiroshima, Michael J Hamann, Saso Cemerski, Tracie Kloeppel, Daniel D Billadeau, Osami Kanagawa, Makio Tokunaga and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Vav2 lacks CaJournal of cell science · 2020
    Article
  6. Advances in targeted therapy for malignant lymphoma.Signal transduction and targeted therapy · 2020
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Ana V MileticDepartment of Pathology and Immunology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO, USA.
Daniel B Graham
Kumiko Sakata-Sogawa
Michio Hiroshima
Michael J Hamann
Saso Cemerski
Tracie Kloeppel
Daniel D Billadeau
Osami Kanagawa
Makio Tokunaga
Wojciech Swat
Washington University in St. Louis · USRIKEN Center for Integrative Medical Sciences · JPMayo Clinic · USNational Institute of Genetics · JP

Funding

Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI WEIHL, CONRAD C · 2001 to 2015
$8.9M
Regulation of Actin Dynamics During T Cell ActivationR01AI065474 · NIAID · MAYO CLINIC ROCHESTER · PI BILLADEAU, DANIEL D · 2005 to 2014
$3.1M
Vav Family Proteins in T Lymphocyte ActivationR01AI061077 · NIAID · WASHINGTON UNIVERSITY · PI SWAT, WOJCIECH A · 2004 to 2008
$1.9M
NIAID NIH HHS R01 AI061077NIAID NIH HHS R01-AI061077NIAID NIH HHS R01-AI065447NIAID NIH HHS R01 AI065474NIAMS NIH HHS P30 AR048335NIAMS NIH HHS P30-AR048335
6 · The paper itself

Abstract

backgroundT cell receptor (TCR) engagement leads to formation of signaling microclusters and induction of rapid and dynamic changes in the actin cytoskeleton, although the exact mechanism by which the TCR initiates actin polymerization is incompletely understood. The Vav family of guanine nucleotide exchange factors (GEF) has been implicated in generation of TCR signals and immune synapse formation, however, it is currently not known if Vav's GEF activity is required in T cell activation by the TCR in general, and in actin polymerization downstream of the TCR in particular. METHODOLOGY/PRINCIPAL

findingsHere, we report that Vav1 assembles into signaling microclusters at TCR contact sites and is critical for TCR-initiated actin polymerization. Surprisingly, Vav1 functions in TCR signaling and Ca(++) mobilization via a mechanism that does not appear to strictly depend on the intrinsic GEF activity. CONCLUSIONS/SIGNIFICANCE: We propose here a model in which Vav functions primarily as a tyrosine phosphorylated linker-protein for TCR activation of T cells. Our results indicate that, contrary to expectations based on previously published studies including from our own laboratory, pharmacological inhibition of Vav1's intrinsic GEF activity may not be an effective strategy for T cell-directed immunosuppressive therapy.

Indexed as

Lymphocyte ActivationActinsAnimalsBiopolymersCytoskeletonGuanine Nucleotide Exchange FactorsMiceMice, KnockoutProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellT-LymphocytesActinsBiopolymersGuanine Nucleotide Exchange FactorsProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellVav1 protein, mouse

Identifiers

PMID19672294
PMCPMC2719804
OpenAlexW2116168075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.